Do you suffer from UTIs? URIEXO is the only Natural Health Product licensed by Health Canada that is clinically proven to stop UTIs before they start, in two separate and distinct ways – without the interruption (and pain) caused by UTIs!
URIEXO Double Action is UNIQUE in that it has a double mode of action. Specially formulated with not one but two clinically active ingredients, D-Mannose and Proanthocyanidins (PACs), sourced from cranberry, URIEXO provides you with a two-pronged and scientifically proven defence, against recurring UTIs. These two active ingredients bind with UTI-causing bacteria in your urinary tract in two separate and distinct ways, preventing bacteria from sticking to your bladder wall and urinary tract, so that you can safely flush bacteria out of your system.
URIEXO provides you with a one-two punch against bacteria…SHIELDING you from recurring UTIs…
The two active ingredients found in URIEXO help prevent recurrent urinary infections and its associated symptoms (painful or difficult urination, frequent urination, urgency to urinate, and suprapubic pain). Read more about URIEXO and the URIEXO “double-action” difference by clicking on the following link:
- Helps prevent Urinary Tract Infections and its symptoms:
- Painful or difficult urination
- Frequent urination
- Urgency to urinate
- Suprapubic/pelvic pain
- Two Medicinal Ingredients:
- D-Mannose (2000 mg/day)
- PACs, sourced from cranberry (36mg/day)
- Easy to Swallow Capsules
URIEXO, a Natural Health Product to help prevent Urinary Tract Infections and its symptoms, has been reviewed and approved to be part of the new “Brand Recognition Program” recently introduced by the Society of Obstetricians and Gynaecologists of Canada (SOGC). The SOGC Brand Recognition Program aims to assist Canadian consumers to make informed choices when selecting over-the-counter products. This program is designed for non-prescription/over-the-counter products that are found to safely and effectively promote female sexual and reproductive health.
Eligible products are required to have:
- Received Health Canada licence for sale in the Canadian market;
- Demonstrated reasonable evidence of safety and efficacy, and pose no undue harm;
- Substantiated packaging claims and a perceived low risk.
Products are independently and carefully reviewed by a panel of medical professionals.
FAQs: Click here to find the answers to commonly asked questions on Uriexo and urinary tract infections.